The most recently authorised trials on the EU Clinical Trials Information System (CTIS), the single register for every trial run under the EU Clinical Trials Regulation (536/2014). CTIS holds a far larger historical archive than any one list can usefully show — this register states both numbers rather than picking one.
This register is built from the EU Clinical Trials Information System (CTIS), run by the European Medicines Agency: the single register for every trial authorised under the EU Clinical Trials Regulation (536/2014). CTIS held 12,490 trial records at the last sync on 25 Sep 2026, 03:16 UTC; this register shows the 2,500 most recently authorised of them, a stated recency window rather than the full archive. The list can be downloaded as CSV or JSON.
This page shows the 10 of those trials with a site in Major depressive disorder.
10 of the 2,500 most recently authorised trials in this register list a site in Major depressive disorder; 4 of them are Phase III. Trials are counted by authorisation on CTIS, not by recruitment status, which CTIS does not publish in the same form as ClinicalTrials.gov.
| Phase | Trials | Share |
|---|---|---|
| Phase II | 5 | 50% |
| Phase III | 4 | 40% |
| Phase IV | 1 | 10% |
| Lead sponsor | Trials |
|---|---|
| Region Hovedstaden | 2 |
| Xenon Pharmaceuticals Inc. | 2 |
| Draig Therapeutics Limited | 1 |
| Fundacio Institut De Recerca De L'Hospital De La Santa Creu I Sant Pau | 1 |
| Janssen Cilag International | 1 |
| Neurocrine Biosciences Inc. | 1 |
| Ostfold Hospital Trust | 1 |
| Region Skane | 1 |